Champions Oncology Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Champions Oncology, Inc. (CSBR) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Apr 2024Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018
Operating Activities
Net Income4.70-7.28-5.340.550.36-2.090.13-1.48
Depreciation & Amortization1.641.872.251.631.180.830.610.36
Stock Based Compensation0.651.120.860.910.600.000.000.00
Change in Working Capital-0.62-3.824.242.34-4.032.850.02-1.56
Change in Accounts Receivable-1.44-1.991.31-2.82-2.270.000.000.00
Change in Accounts Payable-1.750.472.470.97-1.250.000.000.00
Change in Other Working Capital2.56-1.610.950.79-1.130.000.000.00
Other Operating Activities1.011.070.950.790.801.380.400.49
Net Cash from Operating Activities7.39-6.143.976.50-1.682.911.86-1.23
Investing Activities
Capital Expenditures-0.39-0.84-2.87-2.383.282.22-0.83-1.23
Sales/Maturities of Investments0.000.000.000.000.110.000.000.00
Other Investing Activities0.000.000.000.000.110.000.000.00
Net Cash from Investing Activities-0.39-0.84-2.87-2.38-3.17-2.22-0.83-1.23
Financing Activities
Debt Repayment-0.15-0.150.000.00-0.17-0.04-0.26-0.03
Common Stock Issued0.320.250.090.211.370.000.000.00
Common Stock Repurchased0.00-0.63-0.070.000.000.000.000.00
Other Financing Activities0.000.000.000.211.374.460.000.00
Net Cash from Financing Activities0.17-0.530.010.211.204.421.200.01
Summary
Net Change in Cash7.17-7.501.114.32-3.665.112.23-2.44
Cash at Beginning of Period2.6210.129.014.698.343.241.013.45
Cash at End of Period9.792.6210.129.014.698.343.241.01
Free Cash Flow7.00-6.971.104.11-4.960.691.03-2.46